Ajanta Pharma bags USFDA nod For Asthma Treatment Pill – The Wiire (blog)


The Wiire (blog)

Ajanta Pharma bags USFDA nod For Asthma Treatment Pill
The Wiire (blog)
Drug giant Ajanta Pharma has bagged final nods from the US health watchdog for generic montelukast pills and oral granules utilized for deterrence as well as cure of asthma and to ease indications of seasonal pollinosis.
Ajanta Pharma Gets US Regulator's Nod for Asthma Treatment DrugNDTV
Ajanta Pharma Receives Approval From USFDA For Asthma Treatment DrugFocus News

all 18 news articles »

View full post on asthma – Google News

50 year-old asthma study once again bound for Aberdeen school bags – Medical Xpress


Medical Xpress

50 year-old asthma study once again bound for Aberdeen school bags
Medical Xpress
"Questions on asthma, eczema and hayfever were included in the questionnaire which went to pupils aged primary five to primary seven. Such conditions were thought to be relevant to education because in those days children with bad asthma were sent to …

View full post on asthma – Google News

Israel : TEVA bags approval from FDA to market generic asthma treatment … – Equities.com


MedPage Today

Israel : TEVA bags approval from FDA to market generic asthma treatment
Equities.com
US Food and Drug Administration (FDA) have given its approval to Teva Pharmaceutical Industries Ltd. for generic versions of asthma and allergies treatment Singulair in adults and children. Made by Merck & Co., brand Singulair has $5 billion in annual
New generic Singulair could save asthma sufferers big bucksConsumerReports.org
Generic Singulair ApprovedWebMD
FDA approves generic versions of asthma, allergy drugDrug Store News
MedPage Today –RTT News –Jerusalem Post
all 52 news articles »

View full post on asthma – Google News

Ventura bags major US partner for COPD/asthma combo copy – Pharma Times

Ventura bags major US partner for COPD/asthma combo copy
Pharma Times
division of an undisclosed leading international pharmaceutical company" for VR315, a combination therapy for chronic obstructive pulmonary disease and asthma that is widely thought to be a generic version of GlaxoSmithKline's blockbuster Advair.
Vectura Signs Up US Partner For VR315 Lung DrugNASDAQ
Vectura signs US license agreement for VR315 productStock Market Wire
Vectura gets new US partner for copy of lung drugReuters
The Pharma Letter –Pharmaceutical Business Review
all 13 news articles »

View full post on asthma – Google News